Bioprocess Containers Market Report Scope & Overview:

The Bioprocess Containers Market was valued at USD 5.12 Billion in 2025 and is expected to reach USD 38.96 Billion by 2035, growing at a CAGR of 22.50% from 2026-2035.

The Bioprocess Containers Market is expected to grow at a rapid pace due to an increase in biopharmaceutical production and use of disposable bioprocess containers, since the biopharmaceutical industry is moving towards the utilization of disposable bioprocess containers instead of stainless steel systems due to benefits like reduced risks of cross contamination, shorter turnaround time, and cost saving. Bioprocess containers, which include both rigid as well as flexible bioprocess containers, have become an integral part of life sciences process, and are involved in cell culture, fermentation, sampling, and storage process.

The increase in development of biologics, demand for sterile processing technologies, and production of monoclonal antibodies, vaccines, and cell/gene therapy treatments will boost the demand further. In addition, the availability of advanced polymer technology along with the trend of personalized medicine in the biopharmaceutical industry will favor the market growth in future years.

In June 2025, Sartorius Stedim Biotech expanded its cleanroom capacity to approximately 9,000 square meters, nearly doubling its previous footprint to address rising global demand for disposable bioprocessing solutions.

To Get More Information On Bioprocess Containers Market - Request Free Sample Report

Bioprocess Containers Market Trends

• Growing adoption of 3D containers supporting high-volume commercial biologics manufacturing at scale.
• Rising demand for environmentally sustainable, recyclable single-use container materials and designs.
• Continued integration of artificial intelligence into bioprocess container monitoring and quality control.
• Increasing localization of single-use bioprocessing manufacturing capacity across emerging pharmaceutical hubs.
• Expanding contract manufacturing and research organization demand for flexible, scalable container systems.

U.S. Bioprocess Containers Market Outlook

The U.S. Bioprocess Containers Market was valued at USD 2.03 Billion in 2025 and is expected to reach USD 15.73 Billion by 2035, growing at a CAGR of 22.72% from 2026-2035.

The U.S. Bioprocess Containers Market growth continues to be reinforced by the presence of leading pharmaceutical and biotechnology companies driving sustained biologics production, robust research and development investment, and the country's concentration of major bioprocess container manufacturers. Domestic demand also benefits from continued expansion of monoclonal antibody, vaccine, and cell and gene therapy manufacturing capacity across the country's biopharmaceutical manufacturing base. Continued supplier investment in expanded domestic manufacturing operations further supports demand as leading companies work to strengthen single-use technology supply chains for biopharmaceutical customers.

In 2026, Thermo Fisher Scientific expanded its bioprocessing manufacturing operations to strengthen single-use technology supply for biologics companies, reinforcing its position as a leading domestic supplier of comprehensive single-use bioprocessing solutions.

Bioprocess Containers Market Segment Analysis

• By Type, the 2D Container segment dominated the Bioprocess Containers Market with approximately 48.50% share in 2025, while the 3D Container segment is the fastest growing with a CAGR of approximately 24.60%.
• By Application, the Upstream Process segment dominated the Bioprocess Containers Market with approximately 42.50% share in 2025, while the Production Process segment is the fastest growing with a CAGR of approximately 23.80%.
• By End-Use, the Pharmaceutical Companies segment dominated the Bioprocess Containers Market with approximately 54.50% share in 2025, while the Biotechnology Companies segment is the fastest growing with a CAGR of approximately 24.20%.

By Type, 2D Container dominates and 3D Container grows fastest

The 2D Containers represent the most popular segment of type of the Bioprocess Containers Market, due to their application in a variety of small-scale processes of cell culture, media storage and sampling across the biopharmaceutical production processes. This segment takes advantage of low-cost and versatile bag-based solutions which have enabled the segment's wide spread in laboratory and pilot-scale bioprocessing applications.

The 3D Containers is currently the most rapidly developing segment of type of the market, thanks to their better utility in high-scale commercial manufacturing processes, in which case the multi-layered and more complex 3D containers allow holding large-scale bioreactor volumes up to 3,000 liters and above. This segment is mainly aimed at providing support for upstream processes such as fermentation and mixing of final bulk drug substance.

By Application, Upstream Process dominates and Production Process grows fastest

Upstream Process applications remain the dominant application segment within the Bioprocess Containers Market, reflecting the gradual digitalization of bioprocessing and heavy reliance on flexible, modular single-use container deployment in cell culture and fermentation processes. This segment benefits from established container designs suited to cell expansion, seed culture, and fermentation workflows that continue to anchor the majority of biopharmaceutical manufacturing operations.

Production Process applications are emerging as the fastest-growing application segment, driven by rising commercial-scale biologics manufacturing requiring reliable, high-capacity container systems throughout the final production stages. This segment focuses on containers engineered to maintain sterility and material integrity through commercial-scale production runs, positioning production process applications to capture growing demand as biopharmaceutical companies continue expanding commercial manufacturing capacity.

By End-Use, Pharmaceutical Companies dominates and Biotechnology Companies grows fastest

Pharmaceutical Companies constitute the major end-user category of the Bioprocess Containers Market due to the huge scale of biologics manufacturing and existing collaborations between pharmaceutical companies and top bioprocess containers manufacturers. Such end-users can make use of large-scale biologics manufacturing processes involving the use of monoclonal antibodies, vaccines, and other biopharmaceuticals and thus will need many bioprocess containers in the long term.

Biotechnology Companies are expected to witness the fastest growth rate among the end-user categories of the market due to the increasing number of cell and gene therapies and other specialty biologics for which single-use containers are necessary. Such end-users are involved in small-batch and high-value biologics manufacturing and hence can benefit much from single-use systems due to the flexibility of such systems and low chances of cross contamination.

Regional Analysis

North America Bioprocess Containers Market Insights

North America accounted for approximately 44.90% of the global Bioprocess Containers Market in 2025, driven by the presence of leading pharmaceutical companies and substantial biologics manufacturing capacity across the region. The United States shapes regional demand dynamics through its concentration of major biopharmaceutical manufacturers and bioprocess container suppliers investing heavily in single-use technology innovation.

Canada contributes additional regional demand through its participation in North American biopharmaceutical manufacturing and research activity. Continued strong biologics production and sustained research and development investment further reinforce North America's position as the largest regional market for bioprocess containers.

Get Customized Report as Per Your Business Requirement - Enquiry Now

Asia Pacific Bioprocess Containers Market Insights

Asia Pacific is projected to expand at the fastest CAGR of around 22.80% across the Bioprocess Containers Market during the 2026-2035 forecast period, driven by government incentives supporting domestic biomanufacturing infrastructure development across the region. China represents the largest single contributor within the region, supported by expanding domestic biopharmaceutical manufacturing capacity and growing biologics production.

India contributes substantial additional regional growth, exemplified by government-backed biomanufacturing infrastructure investment such as the Telangana 1 Bio facility in Genome Valley, dedicated to single-use bioprocess design and scale-up. Japan and South Korea's established biopharmaceutical manufacturing expertise further reinforces the region's overall market development, supporting Asia Pacific's position as the fastest-growing global market for bioprocess containers.

Europe Bioprocess Containers Market Insights

Europe can be observed as an important market region for bioprocess containers due to the presence of Germany which accounts for a significant portion of the European market for bioprocess containers because of its strong infrastructure of biopharmaceutical manufacturing industries along with top-tier academic institutions researching in the biologics sector.

The other European countries such as France and the United Kingdom are also important regional markets for bioprocess containers due to their existing academic research activity which is generating demand for bioprocess containers in these regions.

MEA & Latin America Bioprocess Containers Market Insights

The Middle East & Africa region continues to grow in strategic importance, with demand concentrated in markets such as UAE, which maintains an established biotechnology research and development ecosystem supporting advanced biologics innovation. Gulf Cooperation Council markets contribute additional regional demand through growing investment in life sciences and biomanufacturing infrastructure.

Latin America's Bioprocess Containers Market is led by Brazil, which accounts for the majority of regional demand on the strength of its growing domestic biopharmaceutical manufacturing sector. Gradual growth in domestic biologics production continues to support steady regional market development.

Market Dynamics

Growth Drivers: Single-Use Technology Adoption and Biologics Manufacturing Expansion

Biopharmaceutical production and the use of disposable bioprocess technologies are among the major driving forces behind the growth of the Bioprocess Containers Market, owing to the shift by manufacturers from the traditional stainless-steel technology to single-use systems that pose a low risk of cross contamination and have low operating costs. These developments are driven by the growth of biologics manufacturing and the need for sterilization processes that can cope with complex biopharmaceutical products.

Growth in the production of monoclonal antibodies and increased demand for personalized medicines are another key driver, since biologics manufacturing and the treatment of chronic diseases are on the rise. The availability of innovative polymer materials is expected to help fuel the growth of the market.

Restraints: Regulatory Complexity and Supply Chain Sensitivity

Strict regulations that oversee biopharmaceutical production are some of the major constraints faced in the Bioprocess Containers Market because bioprocess containers require high-quality standards and contamination controls before their commercial application in biologics production processes. In addition, there is the challenge posed by the high cost of bioprocess containers and related equipment compared to conventional manufacturing equipment.

Due to the highly sensitive nature of biologics material to the outside environment factors such as temperature, pH, and moisture, bioprocess containers require more advanced packaging solutions compared to conventional packaging solutions. The unpredictability in the availability of raw materials and polymers presents another constraint to future cost and price projections in manufacturing.

Opportunities: Sustainability Innovation and Emerging Market Manufacturing Localization

Continued focus on environmental sustainability presents a substantial growth opportunity for the Bioprocess Containers Market, as suppliers work to develop bioprocess containers made from sustainable, recyclable materials that reduce environmental impact while maintaining contamination-free performance. Suppliers that can demonstrate validated, sustainable container solutions are well positioned to capture share as biopharmaceutical companies increasingly prioritize supply chain sustainability.

Rising government incentive programs supporting domestic biomanufacturing infrastructure across emerging pharmaceutical hubs present a longer-term opportunity for suppliers to expand their manufacturing footprint beyond traditional North American and European production centers. As countries such as India continue investing in domestic biomanufacturing capability, suppliers with established localized manufacturing capabilities are positioned to capture a disproportionate share of this emerging demand.

Recent Developments:

• 2025: the Telangana state government inaugurated Telangana 1 Bio in Genome Valley, India, a facility dedicated to single-use bioprocess design and scale-up, highlighting increased institutional investment in advanced biomanufacturing infrastructure across emerging pharmaceutical hubs.
• 2026: Avantor unified its Masterflex portfolio of pumps, single-use assemblies, and fluid-management systems, including standard, configurable, and engineered-to-order options with PROFINET-enabled connectivity.
• 2026: ABEC expanded production capacity for large-scale disposable bioreactor technologies to support growing commercial biologics manufacturing demand.

Bioprocess Containers Market Key Players are:

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation (Cytiva)
• Merck KGaA
• Avantor, Inc.
• Corning Incorporated
• Saint-Gobain S.A.
• Lonza Group AG
• Entegris, Inc.
• Parker Hannifin Corporation
• Cole-Parmer Instrument Company, LLC
• ABEC, Inc.
• Antylia Scientific
• Celltainer Biotech B.V.
• Cellexus Limited
• Foxx Life Sciences
• Flexbiosys, Inc.
• Fujimori Kogyo Co., Ltd.
• Keofitt A/S
• Solida Biotech GmbH

Bioprocess Containers Market Report Scope: